A longitudinal study involving 699 adults from the InCHIANTI cohort has revealed that the rate of change in epigenetic clocks—biomarkers derived from DNA methylation patterns—can predict mortality risk more effectively than static measures alone. The research, which tracked participants for up to 24 years, found that faster increases in several epigenetic clocks were significantly associated with a higher risk of death, independent of baseline epigenetic age and other confounding factors. This underscores the potential of dynamic epigenetic changes to reflect an individual’s evolving health status.

These findings are significant for the longevity and healthspan research fields, as they suggest that monitoring the rate of change in epigenetic aging could serve as a sensitive indicator for assessing the effectiveness of interventions aimed at extending healthspan and longevity. The study highlights the superiority of second- and third-generation epigenetic clocks—such as DNAmPhenoAge and DunedinPACE—over first-generation clocks in predicting mortality, emphasizing the need for incorporating both baseline and longitudinal data in future aging studies.

One key takeaway from this research is the importance of integrating longitudinal assessments of epigenetic clocks into health monitoring frameworks. As these clocks provide insights into the biological aging process, they can be instrumental in identifying individuals at greater risk of adverse health outcomes and tailoring interventions to mitigate these risks. This approach could ultimately enhance our understanding of aging trajectories and improve strategies for promoting healthier, longer lives.

Source: nature.com